glp-1 and sarcopenia The Influence of Glucagon-like Peptide-1 Receptor Agonists Other Incretin Hormone Agonists on Body Composition Weighing the risk of GLP-1

It all comes from protein. Hair thinning isnt just cosmetic

The landscape of heart failure (HF) management is evolving alongside a deeper understanding of how metabolic dysfunction drives cardiac pathology and the progression of HF, particularly in phenotypes like HF with preserved ejection fraction (HFpEF) associated with obesity

Both Neeland and Ahmed say more research is needed on the health effects from short-term use of GLP-1s.

This growth is driven by the increasing prevalence of type 2 diabetes and obesity, with GLP-1 receptor agonists offering effective treatment options that help manage blood sugar levels, promote weight loss, and reduce cardiovascular risks